Arthritis Research Canada, Vancouver, British Columbia, Canada and Footscray Hospital, Western Health, Melbourne, Victoria, Australia.
Arthritis Research Canada, Vancouver, British Columbia, Canada and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Arthritis Care Res (Hoboken). 2019 Jan;71(1):155-163. doi: 10.1002/acr.23587.
To investigate all-cause and cause-specific mortality in patients with newly diagnosed granulomatosis with polyangiitis (GPA) between 2 calendar time periods, 1997-2004 and 2005-2012.
Using an administrative health database, we compared all patients with incident GPA with non-GPA controls matched for sex, age, and time of entry into the study. The study cohorts were divided into 2 subgroups based on the year of diagnosis ("early cohort [1997-2004] and "late cohort" [2005-2012]). The outcome was death (all-cause, cardiovascular disease [CVD]-related cancer-related, renal disease-related, and infection-related) during the follow-up period. Hazard ratios (HR) were estimated using Cox proportional hazards models, first adjusted for age, sex, and time of entry and then adjusted for selected covariates based on a purposeful selection algorithm.
Three hundred seventy patients with GPA and 3,700 non-GPA controls were included in this study, contributing 1,624.8 and 1,8671.3 person-years of follow-up, respectively. Sixty-eight deaths occurred in the GPA cohort, and 310 deaths occurred in the non-GPA cohort. Overall, the age-, sex-, and entry time-adjusted all-cause mortality HR in the GPA cohort was 3.12 (95% confidence interval CI 2.35-4.14). There was excess mortality due to CVD-related causes, but not cancer, in the GPA cohort. Reports of death due to infection or renal disease was not permitted, because the numbers of death were insufficient (<6 deaths for each outcome). All-cause mortality significantly improved between the early cohort and late cohort time periods (HR 5.61 and 2.33, respectively; P for interaction = 0.017).
This population-based study showed increased all-cause and CVD-related mortality risks in patients with GPA. There was significant improvement in the all-cause mortality risk over time, but the risk remained increased compared with that in the general population.
在两个日历时间段(1997-2004 年和 2005-2012 年)内,研究新诊断的肉芽肿性多血管炎(GPA)患者的全因死亡率和特定病因死亡率。
利用一个行政健康数据库,我们将所有患有 GPA 的患者与非 GPA 对照者进行比较,这些对照者按性别、年龄和研究入组时间进行匹配。根据诊断年份,将研究队列分为 2 个亚组(“早期队列[1997-2004 年]”和“晚期队列[2005-2012 年]”)。研究结果是随访期间的死亡(全因、心血管疾病[CVD]相关、癌症相关、肾脏疾病相关和感染相关)。使用 Cox 比例风险模型估计风险比(HR),首先根据年龄、性别和入组时间进行调整,然后根据有目的的选择算法,根据选定的协变量进行调整。
这项研究纳入了 370 名 GPA 患者和 3700 名非 GPA 对照者,分别随访 1624.8 和 18671.3 人年。GPA 队列中有 68 例死亡,非 GPA 队列中有 310 例死亡。总体而言,GPA 队列的年龄、性别和入组时间调整后的全因死亡率 HR 为 3.12(95%置信区间[CI]为 2.35-4.14)。GPA 队列中存在 CVD 相关原因导致的死亡率过高,但癌症死亡率并未增加。由于每种结局的死亡人数不足(每种结局的死亡人数<6 例),因此未报告感染或肾脏疾病导致的死亡。全因死亡率在早期队列和晚期队列时间之间显著改善(HR 分别为 5.61 和 2.33;P 交互=0.017)。
这项基于人群的研究表明,GPA 患者的全因和 CVD 相关死亡率风险增加。随着时间的推移,全因死亡率风险显著降低,但与普通人群相比,风险仍然增加。